Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Electromotive Mitomycin-C (EMDA-MMC) in Preventing Recurrences in High-risk Non-muscle-invasive Bladder Cancer (FB10)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03664869
Recruitment Status : Recruiting
First Posted : September 11, 2018
Last Update Posted : April 24, 2019
Sponsor:
Collaborator:
Finnbladder
Information provided by (Responsible Party):
Turku University Hospital

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : November 1, 2023
Estimated Study Completion Date : November 1, 2025
Publications of Results:
Other Publications: